Insider Transactions in Q1 2023 at Arvinas, Inc. (ARVN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
5,878
-0.64%
|
$170,462
$29.53 P/Share
|
|
Mar 01
2023
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,510
+1.86%
|
-
|
|
Mar 01
2023
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,051
-1.02%
|
$30,479
$29.53 P/Share
|
|
Mar 01
2023
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,685
+2.55%
|
-
|
|
Mar 01
2023
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,745
-0.94%
|
$50,605
$29.53 P/Share
|
|
Mar 01
2023
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,791
+2.52%
|
-
|
|
Feb 22
2023
|
Ian Taylor Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,125
+16.04%
|
-
|
|
Feb 22
2023
|
John G Houston President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
61,975
+6.4%
|
-
|
|
Feb 22
2023
|
Ronald Peck Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,125
+41.21%
|
-
|
|
Feb 22
2023
|
Sean A Cassidy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,125
+9.58%
|
-
|